Neurocrine Biosciences Announces Successful Elagolix PETAL Study in End... (* -3.7* -3.8* Week 24...)

HOME >> MEDICINE >> TECHNOLOGY

Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis

Date:9/2/2008

* -3.7* -3.8*

Week 24 mean -5.5* -5.2* -5.3*

Dysmenorrhea 2.4

Week 24 mean -1.5* -1.4* -1.7*

Responder Rate 86% 74% 86%

Non-Menstrual Pelvic

Pain 2.2

Week 24 mean -1.2* -1.2* -1.1*

Responder Rate 86% 77% 77%

VAS 78.7

Week 24 mean -31.8* -33.4* -35.5*

*ITT Analysis, p<0.0001

"We have treated over 600 subjects with elagolix in our extensive endometriosis clinical program, and have consistently seen a robust reduction in endometriosis pain using multiple outcome measures. In our previous Phase II studies we have shown rapid onset of action and sustained efficacy over three months. This study extends those findings, demonstrating significant and sustained pain reduction for six months," said Dr. O'Brien. "There is much more data to come from this study once patients complete the six month follow-up and the study is unblinded at an individual patient level. At that time we will be able to make correlations between pain scores, BMD, pharmacokinetic values, and hormonal levels on an individual patient basis, and we look forward to also sharing those results, as soon as they are available."

Treatment with elagolix was also safe and generally well tolerated. Discontinuation from the clinical trial due to adverse events (AE) was more common among women randomized to DMPA (16%) than those receiving elagolix 150 mg once daily (5%) or 75 mg twice daily (7%). This increased discontinuation in women randomized to DMPA was primarily attributable to irregular vaginal bleeding. The overall rate of AE reporting was comparable across all groups. The most common AE was headache;
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
2. Neurocrine Biosciences Reports First Quarter 2008 Results
3. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
4. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
5. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
6. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
7. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
10. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
11. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells

Post Your Comments:

(Date:5/20/2013)... , May 20, 2013 National Community Pharmacists ... , RPh, MBA issued the following statement today ... regarding Medicare Part D "preferred pharmacy" drug plans ... patients the plan,s lowest advertised co-payments: (Logo: ... Medicare and MedPAC , 16 U.S. ...

(Date:5/20/2013)... , May 20, 2013 Hill-Rom Holdings, Inc. (NYSE: ... a management presentation at the 38 th Annual ... on May 30, 2013, at 1:30 p.m. ... You are invited to listen to the live ... or access it directly at http://www.media-server.com/m/p/f7bj3q84 . A ...

(Date:5/20/2013)... , May 20, 2013 Sequent Medical, Inc. ... the SL ("Single Layer") family of WEB ® ... of these new models in select neurovascular centers in ... superior navigability that will enable physicians to treat a ... The SL configurations are made possible by further ...

Breaking Medicine Technology:Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2 Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3 Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4 Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2

[0] Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans [0] Hill-Rom to Participate in the 38th Annual Deutsche Bank Health Care Conference [0] Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices

... Computerized tomographic (CT),colonography, also known as virtual colonoscopy, ... flexible tube with a camera to view the,lining ... detect cancer and,precancerous polyps and could serve as ... the results of the American College of,Radiology Imaging ...

... Department of,Justice announced today that it will not ... (CRC) to develop and publicize model contract language,for ... Department said,the language is not likely to be ... in contract negotiations, potentially reducing costs,and shortening the ...

Cached Medicine Technology:Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy 2 Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy 3 Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy 4 Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal 2

Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal

(Date:5/21/2013)... May 21, 2013 Joe Vitale, a positive ... early adapter of the Fisker electric car. After a year ... since the car company went bankrupt, the bestselling author turned ... , "It's a gas guzzler's anthem," says Vitale, 59, ... album, "Sun Will Rise." , Owning this Fisker was ...

(Date:5/21/2013)... 21, 2013 Limited mobility affects ... Not only is it more difficult to walk around, but ... Fortunately, there are a variety of medical products made to ... product is the raised toilet seat. , Raised toilet ... easier to stand back up or sit down. They come ...

(Date:5/20/2013)... 2013 This week has been dedicated as ... (May 19th-May 25th) is an awareness campaign designated to help ... encouraging dog owners to properly train their pets, and educate ... dog bite lawyers at Buckfire & Buckfire, P.C. represent ... Michigan. The personal injury law firm is a large advocate ...

(Date:5/20/2013)... 2013 Recent environmental concerns have ... green and sustainable inputs in packaging products. As ... to promote the use of sustainable materials, thereby ... Services industry . “Tax subsidies and operating cost ... industry analyst Deonta Smith. “For example, many packaging ...

(Date:5/20/2013)... Daily Gossip, online magazine about lifestyle, health and sports issues, ... can help them overcome one of the most spread skin ... Vitiligo Treatment System has created a buzz on the ... from the persons who have tried it. Its principles have ... some of the people who tried it and managed to ...

Breaking Medicine News(10 mins):Health News:Upset Fisker Owner Records Gas Guzzler Anthem 2 Health News:JustHomeMedical.com Launches Raised Toilet Seats Category 2 Health News:Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week 2 Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2 Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3 Health News:New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine 2

[0] Upset Fisker Owner Records Gas Guzzler Anthem [0] JustHomeMedical.com Launches Raised Toilet Seats Category [0] Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week [0] Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld [0] New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine

... ... launches SafeConsole 4.0, the web management software for SafeStick, the secure USB flash drive. ... administrators through a series of new features and range of licensing options. , ... Washington, DC (PRWEB) December ...

... , , ... a new market research report is available in ... Industry in the U.S. and its International Trade ... , The newly published In-Vitro Diagnostic Substance Manufacturing ...

... , , , ... a new market research report is available in ... Autoimmune Diseases Therapeutics - Market Forecasts to 2015, ... , http://www.reportlinker.com/p0168100/The-Future-of-Autoimmune-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html , Summary ...

... , SANTA CLARA, Calif., Dec. 15 ... into Santa Clara County for the first time since ... Administrators will be assuming responsibilities and provider contracts previously ... , Operating on a locally based healthcare philosophy, Coastal ...

... is widely thought to be the major form of the ... Research Program (MHRP) researchers, however, have demonstrated that essentially all ... of red blood cells isolated from each of 30 normal ... PLoS ONE , and can be accessed here. ...

... 2009Do good-looking people really benefit from their looks, and in ... Georgia and the University of Kansas found that yes; attractive ... an increased sense of psychological well-being. This seems like common ... each year trying to become more attractive. However, the study, ...

BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Coastal Healthcare Administrators Expands Provider Network to Santa Clara County New insight into selective binding properties of infectious HIV The importance of attractiveness depends on where you live

... Extremely accurate detections of ... well as glaucoma in ... be performed. Smooth operation ... perimetry. High accuracy of ...

... FDT is a breakthrough in visual field testing ... in pre-test. Introducing FDT, the first visual field ... enough to be used even in pre-test. Affordably ... trials behind it to validate performance. The instrument ...

... Matrix represents the latest breakthrough in ... technology, the Humphrey Matrix will help ... evaluation and assess treatment alternatives. Enhanced ... provide complete long-term glaucoma care for ...

... Exceptional comfort for those with ... Toric soft contact lenses let you enjoy ... other soft toric lensa difference youll especially ... throughout the day., This exceptional level of ...

Medicine Products:

Perimeter Humphrey FDT Perimeter Humphrey Matrix Proclear® Toric